Department of Physiotherapy and Intensive Care, Southern Health, Melbourne, VIC, Australia.
Crit Care Resusc. 2013 Sep;15(3):205-12.
Multiattribute utility (MAU) instruments are short instruments measuring quality of life, health utility scores and treatment cost-effectiveness. Many studies have compared MAU instruments, but few have involved intensive care unit patients. Our aim was to compare the measurement properties of two MAUs, the assessment of quality of life (AQoL) and Medical Outcomes Study Short Form 6D (SF-6D), in a sample of patients with critical illness.
Prospective observational study conducted in an 18-bed mixed tertiary Australian ICU. Eligibility criteria were: admitted to the ICU > 48 hours, aged > 18 years, and not imminently at risk of death. Participants completed the AQoL and SF-6D on admission to the ICU as a "then-test" of pre-ICU status, and 6 months after ICU discharge. We assessed the reliability, validity, sensitivity and responsiveness of the instruments.
Median age was 61 years (interquartile range [IQR], 49-73 years)], 60% were men, and the median Acute Physiology and Chronic Health Evaluation II score was 17 (IQR, 13-21). Cronbach's α was acceptable for the AQoL (α = 0.81) but not for the SF-6D (α = 0.65). The AQoL and SF-6D showed evidence of validity but, despite moderate agreement between their utilities, their scores were not interchangeable. This was likely due to the SF-6D's truncated scoring range. The AQoL was predictive of hospital readmission but the responsiveness and sensitivity of the instruments varied by clinical condition.
The AQoL and SF-6D demonstrated acceptable measurement properties in the ICU population, but the findings raised questions about the reliability and predictive power of the SF-6D. Further research is required to determine the most appropriate instrument for use in measuring health utility in the ICU population.
多属性效用(MAU)工具是一种简短的衡量生活质量、健康效用评分和治疗成本效益的工具。许多研究已经比较了 MAU 工具,但很少涉及重症监护病房患者。我们的目的是比较两种 MAU 工具,即生活质量评估(AQoL)和医疗结果研究短表 6 维度(SF-6D),在一组患有危重病的患者中的测量特性。
在一个 18 张床位的澳大利亚混合三级重症监护病房进行前瞻性观察研究。入选标准为:入住 ICU 超过 48 小时,年龄大于 18 岁,且没有立即死亡的危险。参与者在入住 ICU 时完成 AQoL 和 SF-6D 作为 ICU 前状态的“彼时测试”,并在 ICU 出院后 6 个月时再次完成。我们评估了这些工具的可靠性、有效性、敏感性和反应性。
中位年龄为 61 岁(四分位距 [IQR],49-73 岁),60%为男性,急性生理学和慢性健康评估 II 评分中位数为 17(IQR,13-21)。AQoL 的 Cronbach's α 可接受(α=0.81),但 SF-6D 的 Cronbach's α 不可接受(α=0.65)。AQoL 和 SF-6D 均具有有效性证据,但尽管它们的效用具有中等一致性,但其得分不可互换。这可能是由于 SF-6D 的截断评分范围。AQoL 可预测住院再入院,但工具的反应性和敏感性因临床状况而异。
AQoL 和 SF-6D 在 ICU 人群中表现出可接受的测量特性,但这些发现对 SF-6D 的可靠性和预测能力提出了质疑。需要进一步研究以确定最适合用于测量 ICU 人群健康效用的工具。